DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
VEBRELTINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Unknown
VEBRELTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
2WZP8A9VFN
Molecule Type:
Small molecule
Molecular Formula:
C20H15F3N8
Molecular Weight:
424.39
AlogP:
3.49
PSA:
78.72
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CORT125281
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CORT125281
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TINOSTAMUSTINE
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Melanoma; Multiple Myeloma
Unknown
TINOSTAMUSTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
29DKI2H2NY
Molecule Type:
Small molecule
Molecular Formula:
C19H28Cl2N4O2
Molecular Weight:
415.37
AlogP:
3.86
PSA:
70.39
HBD:
2.0
HBA:
#RotB:
12.0
Source:
RG7342
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 5 modulator
RG7342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LMP-744
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
LMP-744
×
Maximum Phase:
1
First Approval:
None
UNII:
29BY7HQV0T
Molecule Type:
Small molecule
Molecular Formula:
C24H24N2O7
Molecular Weight:
452.46
AlogP:
1.93
PSA:
108.25
HBD:
2.0
HBA:
#RotB:
8.0
Source:
VALINE
1
Small molecule
Investigational
Unknown
Unknown
Renal Insufficiency, Chronic
Unknown
VALINE
×
Maximum Phase:
1
First Approval:
None
UNII:
HG18B9YRS7
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.05
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
2.0
Source:
VS-5584
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Mesothelioma
PI3-kinase class I inhibitor
VS-5584
×
Maximum Phase:
1
First Approval:
None
UNII:
W71J4X250V
Molecule Type:
Small molecule
Molecular Formula:
C21H14F2N6O2
Molecular Weight:
420.38
AlogP:
3.11
PSA:
90.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PSI-697
1
Small molecule
Investigational
Unknown
Unknown
Scleritis
Unknown
PSI-697
×
Maximum Phase:
1
First Approval:
None
UNII:
LH1XC916ME
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClNO3
Molecular Weight:
367.83
AlogP:
4.76
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PBF-999
1
Small molecule
Investigational
Unknown
Unknown
Huntington Disease; Neoplasms
Adenosine A2a receptor antagonist
PBF-999
×
Maximum Phase:
1
First Approval:
None
UNII:
DY6W3NQA36
Molecule Type:
Small molecule
Molecular Formula:
C9H8BrN7
Molecular Weight:
294.12
AlogP:
0.45
PSA:
94.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
WX-037
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase class I inhibitor
WX-037
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Bile Duct Neoplasms; Cholangiocarcinoma
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CEP-7055
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
CEP-7055
×
Maximum Phase:
1
First Approval:
None
UNII:
AD6CBG7OXO
Molecule Type:
Small molecule
Molecular Formula:
C32H35N3O4
Molecular Weight:
525.65
AlogP:
5.03
PSA:
72.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
MGS-0210
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MGS-0210
×
Maximum Phase:
1
First Approval:
None
UNII:
12XH8EKL2A
Molecule Type:
Small molecule
Molecular Formula:
C22H28Cl2FNO5
Molecular Weight:
476.37
AlogP:
4.53
PSA:
98.85
HBD:
2.0
HBA:
#RotB:
11.0
Source:
SALVIANOLIC ACID A
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetic Neuropathies
Unknown
SALVIANOLIC ACID A
×
Maximum Phase:
1
First Approval:
None
UNII:
51622542XO
Molecule Type:
Small molecule
Molecular Formula:
C26H22O10
Molecular Weight:
494.45
AlogP:
3.34
PSA:
184.98
HBD:
7.0
HBA:
#RotB:
8.0
Source:
RINTODESTRANT
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Ductal
Unknown
RINTODESTRANT
×
Maximum Phase:
1
First Approval:
None
UNII:
W3Y784Y0ES
Molecule Type:
Small molecule
Molecular Formula:
C26H19FO5S
Molecular Weight:
462.5
AlogP:
6.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SPIRADOLINE
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder
Unknown
SPIRADOLINE
×
Maximum Phase:
1
First Approval:
None
UNII:
N18ZH0M4NP
Molecule Type:
Small molecule
Molecular Formula:
C22H30Cl2N2O2
Molecular Weight:
425.4
AlogP:
4.56
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ETHANE DIMETHANE SULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Renal Cell; Colonic Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin
Unknown
ETHANE DIMETHANE SULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
EW8V7BJ66Q
Molecule Type:
Small molecule
Molecular Formula:
C4H10O6S2
Molecular Weight:
218.25
AlogP:
-1.06
PSA:
86.74
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CHLORCYCLIZINE
1
Small molecule
Investigational
Unknown
Unknown
Hypersensitivity
Unknown
CHLORCYCLIZINE
×
Maximum Phase:
1
First Approval:
None
UNII:
M26C4IP44P
Molecule Type:
Small molecule
Molecular Formula:
C18H21ClN2
Molecular Weight:
300.83
AlogP:
3.68
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SNDX-5613
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNDX-5613
×
Maximum Phase:
1
First Approval:
None
UNII:
LZ0M43NNF2
Molecule Type:
Small molecule
Molecular Formula:
C76H106F2N12O20S2
Molecular Weight:
1609.88
AlogP:
4.68
PSA:
107.97
HBD:
1.0
HBA:
#RotB:
11.0
Source:
GSK-923295A
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-923295A
×
Maximum Phase:
1
First Approval:
None
UNII:
072702W9QD
Molecule Type:
Small molecule
Molecular Formula:
C32H38ClN5O4
Molecular Weight:
592.14
AlogP:
4.51
PSA:
108.2
HBD:
3.0
HBA:
#RotB:
12.0
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LB-102
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
LB-102
×
Maximum Phase:
1
First Approval:
None
UNII:
N81WKW91XF
Molecule Type:
Small molecule
Molecular Formula:
C18H29N3O4S
Molecular Weight:
383.51
AlogP:
1.74
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
8.0
Source:
FF-10101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
FF-10101
×
Maximum Phase:
1
First Approval:
None
UNII:
7V7IHI0SYG
Molecule Type:
Small molecule
Molecular Formula:
C29H38N8O2
Molecular Weight:
530.68
AlogP:
3.13
PSA:
126.28
HBD:
3.0
HBA:
#RotB:
13.0
Source:
RAD-140
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
RAD-140
×
Maximum Phase:
1
First Approval:
None
UNII:
4O87Q44KNC
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN5O2
Molecular Weight:
393.83
AlogP:
3.98
PSA:
118.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CAFUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
CAFUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CXD-101
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CXD-101
×
Maximum Phase:
1
First Approval:
None
UNII:
5TNV87ICD2
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O
Molecular Weight:
403.53
AlogP:
3.94
PSA:
76.18
HBD:
2.0
HBA:
#RotB:
5.0
Source:
IMD-2560
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-2560
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYPERICIN
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell; Photochemotherapy; Psoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
Unknown
HYPERICIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7V2F1075HD
Molecule Type:
Small molecule
Molecular Formula:
C30H16O8
Molecular Weight:
504.45
AlogP:
5.08
PSA:
155.52
HBD:
6.0
HBA:
#RotB:
0.0
Source:
TAPOTOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Multiple Myeloma
Unknown
TAPOTOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
97W7N9T08G
Molecule Type:
Small molecule
Molecular Formula:
C33H41ClN2O5S
Molecular Weight:
613.22
AlogP:
5.9
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
1.0
Source:
METHANESULFONYL FLUORIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHANESULFONYL FLUORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
9H250YYY0R
Molecule Type:
Small molecule
Molecular Formula:
CH3FO2S
Molecular Weight:
98.1
AlogP:
-0.08
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PF-05180999
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders; Schizophrenia
Unknown
PF-05180999
×
Maximum Phase:
1
First Approval:
None
UNII:
5L84K4IEN9
Molecule Type:
Small molecule
Molecular Formula:
C19H17F3N8
Molecular Weight:
414.4
AlogP:
3.12
PSA:
77.03
HBD:
0.0
HBA:
#RotB:
3.0
Source:
1
2
…
64
65
66
67
68
69
70
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA